Moderators:
|
|
Created: 01/04/2016 10:07:09 AM -
Followers:
15
- Board type:
Free
- Posts Today: 0
|
|
|
OncoCyte is a 76.39% owned subsidiary of BioTime, Inc (BTX)
OncoCyte is developing proprietary non-invasive tests using liquid biopsies (blood and urine) to help physicians improve the screening protocols for lung, breast and bladder cancer patients. OncoCyte’s portfolio of pipeline products detect biomarkers that are associated with specific types of cancer (lung, breast and bladder) to help physicians by confirming false positives to improve the standard of care and reduce overall health care spend.